3,057 results on '"Fabbrocini, Gabriella"'
Search Results
2. AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
3. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
4. Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage
5. The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
6. Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
7. Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data
8. Skin Diseases from Marine Environment
9. Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study
10. Chronic Urticaria in Older Adults: Treatment Considerations
11. Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
12. The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients
13. Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative
14. Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
15. Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study
16. A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and the Tolerability of a Class II Medical Device in the Treatment of Mild and Moderate Acne
17. Update on the Management of Pediatric Psoriasis: An Italian Consensus
18. Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period
19. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
20. A Case of New-Onset Lichen Planus after COVID-19 Vaccination
21. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
22. Antiflammatory activity and potential dermatological applications of characterized humic acids from a lignite and a green compost
23. Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
24. Microneedling for Neocollagenesis of the Face
25. Trichoscopy findings of frontal fibrosing alopecia on the eyebrows: A study of 151 cases
26. The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients
27. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group
28. Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS
29. Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
30. Looking into a Better Future: Novel Therapies for Metastatic Melanoma
31. Hair in Dermatologic Disease
32. Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience
33. Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
34. The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis
35. The effect of the ketogenic diet on Acne: Could it be a therapeutic tool?
36. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
37. Severe symptomatic late onset dermographism after mRNA COVID-19 vaccine
38. Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
39. Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
40. A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
41. Cytometric analysis of patients with COVID-19: what is changed in the second wave?
42. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
43. Phase angle and Mediterranean diet in patients with acne: Two easy tools for assessing the clinical severity of disease
44. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19
45. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
46. Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
47. Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
48. Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review
49. Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis
50. The increase of mTOR expression is consistent with FoxO1 decrease at gene level in acne but not in psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.